Trial Profile
A Randomized, Multi-Center, Double-Blind, Vehicle-Controlled Study Evaluating the Efficacy and Safety of Product 33525 in Subjects With Tinea Pedis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Apr 2014
Price :
$35
*
At a glance
- Drugs Luliconazole (Primary)
- Indications Erythema; Pruritus; Tinea pedis
- Focus Therapeutic Use
- Sponsors Medicis Pharmaceutical Corporation
- 21 Apr 2014 New trial record